NCT01217814 - Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α Blockers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Sarilumab

"Pharmaceutical form: solution for injection~Route of administration: subcutaneous"

DRUG

Placebo

"Pharmaceutical form: solution for injection~Route of administration: subcutaneous"

DRUG

Golimumab

"Pharmaceutical form: solution for injection~Route of administration: subcutaneous"

DRUG

methotrexate (MTX)

"Pharmaceutical form: tablet or solution for injection~Route of administration: Oral (tablet) or subcutaneous, intramuscular (solution)"

DRUG

Folic/folinic acid

"Pharmaceutical form: tablet~Route of administration: oral Folic/folinic acid continued according to local standard."

Trial Locations (14)

11201

Investigational Site Number 840043, New York

16132

Investigational Site Number 380005, Genova

33006

Investigational Site Number 724004, Oviedo

34270

Investigational Site Number 484008, Durango

38305

Investigational Site Number 840025, Jackson

44690

Investigational Site Number 484002, Guadalajara

46009

Investigational Site Number 724002, Valencia

50141

Investigational Site Number 380002, Florence

68601

Investigational Site Number 203002, Uherské Hradiště

78705

Investigational Site Number 840038, Austin

07728

Investigational Site Number 840026, Freehold

Unknown

Investigational Site Number 170004, Barranquilla

Investigational Site Number 170005, Barranquilla

Investigational Site Number 170007, Bucaramanga